U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06865417) titled 'A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis' on March 04.
Brief Summary: The aim of this study is to evaluate the efficacy, safety, tolerability, and pharmacokinetics (PK) of filgotinib as a treatment for UC in children and adolescents aged from 8 to less than 18 years.
Approximately 80 subjects from 8 to <18 years of age with moderately to severely active UC, including a minimum of 8 subjects from 8 to <12 years of age, will be enrolled in this study.
During the study, eligible subjects will take the investigational product (IP) on-site at Week 4, Week 10, and Week 22 (in the mor...